-
公开(公告)号:US20140218115A1
公开(公告)日:2014-08-07
申请号:US14173647
申请日:2014-02-05
CPC分类号: H03F3/45071 , H03F3/45183 , H03F3/45744
摘要: Disclosed is a current compensation circuit. During calibration of a compensation current, a digital control circuit delivers a digital signal with values varying over time to a current compensation array, the current compensation array outputs different amounts of compensation current based on the digital signal with values varying over time, the digital control circuit latches a value of the digital signal, which results in a best compensation current, based on influences of the different amounts of compensation current on a parameter to be calibrated, to complete the calibration. Upon and after completion of the calibration, the digital control circuit continuously delivers the digital signal with the latched value to the current compensation array, and the current compensation array outputs the best compensation current based on the digital signal with the latched value.
摘要翻译: 公开了一种电流补偿电路。 在校正补偿电流期间,数字控制电路将具有随时间变化的值的数字信号传递到电流补偿阵列,电流补偿阵列基于具有随时间变化的值的数字信号输出不同量的补偿电流,数字控制 电路锁存数字信号的值,根据补偿电流的不同量对待校准的参数的影响,产生最佳的补偿电流,以完成校准。 在完成校准之后,数字控制电路将具有锁存值的数字信号连续地传送到电流补偿阵列,并且电流补偿阵列基于具有锁存值的数字信号输出最佳补偿电流。
-
公开(公告)号:US20170319560A1
公开(公告)日:2017-11-09
申请号:US15523256
申请日:2015-10-27
申请人: NIGEL LIVERTON , SCOTT D. KUDUK , DOUGLAS BESHORE , YUNFU LUO , NA MENG
发明人: NIGEL LIVERTON , SCOTT D. KUDUK , DOUGLAS BESHORE , YUNFU LUO , NA MENG
IPC分类号: A61K31/445 , C07D409/14 , C07D401/14 , C07D413/14 , C07D401/04
CPC分类号: A61K31/445 , C07D401/04 , C07D401/14 , C07D409/14 , C07D413/14 , C07D471/04
摘要: The present invention is directed to pyrazole, triazole and tetrazole compounds which are antagonists of orexin receptors. The present invention is also directed to uses of the pyrazole, triazole, and tetrazole compounds described herein in the potential treatment or prevention of neurological and psychiatric disorders and diseases in which orexin receptors are involved. The present invention is also directed to pharmaceutical compositions comprising these compounds. The present invention is also directed to uses of these pharmaceutical compositions in the prevention or treatment of such diseases in which orexin receptors are involved.
-